The Melanoma Research Alliance has announced grants totaling $2.25 million from the Los Angeles-based Saban Family Foundation in support of research to improve the treatment of metastatic melanoma, the most aggressive type of skin cancer.
Awarded through the Saban Family Foundation-MRA Team Science Awards program, the grants will fund three research teams led by a principal investigator at an institution in Israel and comprising researchers from both the United States and Israel. The funded studies, which represent distinctly innovative approaches to melanoma treatment, will focus on TAM receptors as cancer targets, neuroinflammation in melanoma brain metastases, and novel immune checkpoints.
To date, the Saban Family Foundation has awarded more than $51 million to advance the prevention, diagnosis, and treatment of melanoma.
"Melanoma rates continue to increase worldwide, while the rates of other common cancers have been decreasing," said MRA co-founder and chair Debra Black. "Several new treatment options have been made available to melanoma patients in recent years, but there is still an urgent need for better treatments. It will take collaboration from around the globe and all sectors of the research industry to defeat this disease. MRA is incredibly grateful to the Saban Family Foundation for their generous commitment to melanoma research."
For details about each project team, visit the MRA Web site.